Table 60: French Recent Past, Current & Future Analysis for Coronary Stents by Product Segment - Bare Metal Stent and Drug Eluting Stent Markets Independently Analyzed with Annual Sales in Thousand Units for years 2001 through 2010 (includes corresponding Graph/Chart) III-47
The New SIRIUS study did not find a significant difference in the rates of stent thrombosis between the CYPHER([R]) Stent and the bare metal stent when using any of the Academic Research Consortium (ARC) definitions.
WASHINGTON -- Implantation of the CYPHER([R]) Sirolimus-eluting Coronary Stent to treat completely blocked coronary arteries led to substantial reductions in recurrent blockage and the need for repeat treatment compared to bare metal stents in a study presented today at the Transcatheter Cardiovascular Therapeutics 2007 meeting (TCT 2007).
It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Bare Metal Stents (BMS) pipeline products.
The adjusted relative risk of the composite outcome (death or repeat revascularisation) associated with drug-eluting stents or repeat revascularisation associated with drug-eluting stents relative to bare metal stents was 0.
Washington, Mar 29 (ANI): Drug-eluting stents are much safer and superior to bare metal stents in preventing death and heart attacks among cardiac patients, according to researchers from Duke University Medical Center.